New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 12, 2013
09:05 EDTSUNE, RHHBY, UNS, ATHN, FB, IAG, SIGM, PRTA, ORCL, CIEN, VRA, ERJ, BAXS, IMUC, LULUOn The Fly: Pre-market Movers
HIGHER: Facebook (FB), up 4% after announcement company will join S&P 500 after 12/20 close... UNS Energy (UNS), up 29% after acquired by Canada's Fortis for $60.25 per share... Embraer (ERJ), up 5% after receiving order from American Airlines for up to 150 aircraft... Baxano (BAXS), up 25% after announcing final payment decision from Centers for Medicare & Medicaid... Prothena (PRTA), up 8.5% after announcing collaboration with Roche (RHHBY) on antibodies for treatment of Parkinson's disease. DOWN AFTER EARNINGS: Lululemon (LULU), down 8.5%... Vera Bradley (VRA), down 7.3%... Ciena (CIEN), down 6.3%... athenahealth (ATHN), down 9.5%... Sigma Designs (SIGM), down 17%. ALSO LOWER: ImmunoCellular (IMUC), down 59% after ICT-107 study primary endpoint of OS not statistically significant... Oracle (ORCL), down 2% following downgrades at RBC Capital, Morgan Stanley... SunEdison (SUNE), down 8% after cutting its semiconductor materials revenue outlook and announcing a plan to refinance its debt... IAMGOLD (IAG), down 3% after suspending future dividend payments until further notice.
News For FB;LULU;CIEN;ATHN;IMUC;ORCL;UNS;BAXS;PRTA;RHHBY;ERJ;SIGM;SUNE;VRA;IAG From The Last 14 Days
Check below for free stories on FB;LULU;CIEN;ATHN;IMUC;ORCL;UNS;BAXS;PRTA;RHHBY;ERJ;SIGM;SUNE;VRA;IAG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
April 9, 2014
07:22 EDTATHNathenahealth confirms OIG terminates advisory opinion on HIE pricing
Subscribe for More Information
07:22 EDTORCLOracle management to meet with Deutsche Bank
Meetings to be held in Zurich/Milan on April 9 hosted by Deutsche Bank.
07:15 EDTFBJPMorgan sees opportunities in Internet stocks after pullback
JPMorgan believes the recent sell-off in Internet stocks has created opportunities in companies it feels has strong fundamentals, namely Facebook (FB), Priceline (PCLN), Netflix (NFLX) and Pandora (P).
07:08 EDTIAGIAMGOLD updates activities at Pitangui, Brazil, and Boto Gold, Senegal, projects
Subscribe for More Information
06:54 EDTFBIndia Facebook's second top market with over 100M users, FT says
Facebook confirmed that more than 100M people in India now access its services each month, which is up from just 8M in the middle of 2010 and makes the nation the second top market for the social network, trailing only the U.S., reported Financial Times. Reference Link
06:03 EDTFBFacebook making slight changes to privacy settings, Re/code reports
Re/code reports that Facebook is slightly tweaking its privacy settings in a move to minimize "accidental sharing incidents." The company is also testing privacy surveys to see which features users are not comfortable with. Reference Link
April 8, 2014
16:21 EDTFBOn The Fly: Closing Wrap
Subscribe for More Information
16:10 EDTPRTA, RHHBYProthena says first human dosed in Phase 1 study of PRX002
Prothena (PRTA) announced the successful start of a Phase 1 clinical trial of its therapeutic monoclonal antibody candidate, PRX002, for the treatment of Parkinson's disease. Prothena has earned a $15M milestone payment from Roche (RHHBY) related to the initiation of this study. The initial Phase 1 clinical trial of PRX002 is a randomized, double-blind, placebo-controlled, single ascending dose study in healthy subjects. It is designed to assess PRX002 for safety, tolerability, pharmacokinetics and immunogenicity. As previously announced in December 2013, Prothena entered into a worldwide collaboration with Roche to develop and commercialize antibodies that target α-synuclein, including PRX002. Including the current milestone payment, Prothena has now achieved a total of $45M through its worldwide PRX002 collaboration with Roche.
11:03 EDTRHHBYPiper Jaffray's biopharm analyst holds an analyst/industry conference call
Biopharm Analyst Schimmer discusses PCSK9 Inhibitors and other atherosclerosis approaches on an Analyst/Industry conference call. Relevant companies AEGR, ALNY, AMGN, ARNA, AZN, BMY, CBST, LLY, ESPR, GSK, ICPT, ISIS, MNKD, MRK, OREX, PFE, REGN, RHHBY, SNY and VVUS may be included on the Analyst/Industry conference call to be held on April 10 at 3 pm.
09:00 EDTFBCLSA social media analysts hold an analyst/industry conference call
Subscribe for More Information
08:03 EDTORCLOracle management to meet with Deutsche Bank
Subscribe for More Information
07:28 EDTFBFour Internet stocks attractive after pullbacks, says Stifel
Subscribe for More Information
07:28 EDTFBSecurity Innovation Network to hold a forum
IT Security Entrepreneurs Forum: ITSEF 2014 is being held in Mountain View, California on April 8-9.
April 7, 2014
17:43 EDTORCLFour Oracle insiders sold $69.5M in stock, Barron's says
Subscribe for More Information
13:10 EDTLULUlululemon weekly volatility elevated into Analyst Day
Subscribe for More Information
09:00 EDTORCLOracle management to meet with Deutsche Bank
Subscribe for More Information
07:44 EDTCIENMarketo to hold a summit
Subscribe for More Information
07:39 EDTSUNEBloomberg to hold a summit
The Future of Energy Summit 2014 is being held in New York on April 7-9.
07:38 EDTLULUlululemon reiterated as a Buy ahead of Analyst Day at Topeka
Topeka expects lululemon's April 17 Analyst Day to be a "very positive" event and reiterates its Buy rating and $70 price target ahead of the event. The analyst said the new CEO is on a marketing offensive as the store base expands worldwide and new heads of merchandising and sourcing are working to maintain a high quality, innovative product.
06:07 EDTRHHBYRoche acquires IQuum for $450M
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use